NCT03241121

Brief Summary

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time restricted feeding leads to weight loss, improvement in lipid and glucose metabolism in individuals with components of the metabolic syndrome

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
235

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 7, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

September 29, 2017

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

December 6, 2024

Status Verified

August 1, 2024

Enrollment Period

3.5 years

First QC Date

April 2, 2017

Last Update Submit

December 3, 2024

Conditions

Keywords

Time Restricted FeedingEating patterns

Outcome Measures

Primary Outcomes (2)

  • Eating duration

    Duration from the first to last caloric intake over 24-hour cycle, collected via the smartphone app. Note: Key inclusion criterion for the intervention phase (Part 2).

    From baseline visit to end of observation phase (Part 1: 4 weeks for adults, 2 weeks for teenagers)

  • Change of metabolic syndrome components

    Number of participants with changes in weight and/or lipid profile and/or glucose metabolism in the intervention phase (Part 2). Note: Changes of the different components will be analyzed separately as secondary outcomes.

    From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

Secondary Outcomes (11)

  • Adherence to TRF intervention

    From randomization visit to close-out visit (Part 2: 6 months for adults, 6 weeks for teenagers)

  • Weight change

    From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  • Change in lipid profile

    From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  • Change in glucose metabolism

    From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  • Change in blood pressure

    From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  • +6 more secondary outcomes

Other Outcomes (7)

  • Change in fat mass

    From randomization visit to close-out visit (Part 3: 6 months, only adults)

  • Change in fat free mass

    From randomization visit to close-out visit (Part 3: 6 months, only adults)

  • Change in diurnal rhythms of cortisol secretion

    From randomization visit to close-out visit (Part 3: 6 months, only adults)

  • +4 more other outcomes

Study Arms (2)

Time restricted feeding

EXPERIMENTAL

For those in the intervention phase (Part 2)

Behavioral: Time restricted feedingDevice: Eating patterns

Regular dietary advices

ACTIVE COMPARATOR

For those in the intervention phase (Part 2)

Behavioral: Regular dietary advicesDevice: Eating patterns

Interventions

To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake

Time restricted feeding

Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines

Regular dietary advices

Data collection on eating patterns via the smartphone app

Regular dietary advicesTime restricted feeding

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 12 years
  • Body mass index ≥ 20 kg/m2 and stable weight (previous 3 months) in adults; BMI ≥ 25th percentile in teenagers
  • Smartphone compatible with the app (iOS or Android systems)
  • Any component of the metabolic syndrome following the International Diabetes Federation consensus definition
  • Eating duration \>14h during the observation phase
  • Age 18-40 years, men and pre-menopausal women
  • BMI 30-40 kg/m2
  • In the fasting state (at least 8 hours)

You may not qualify if:

  • Pregnant and breastfeeding women, plans for maternity during the study
  • Major illness/fever over the previous month, active cancer
  • Eating disorder, on a diet / weight management, prior bariatric surgery
  • Major mental illness, unable to give informed consent
  • Current shift work or travel abroad planned in the next month
  • Prior cardiovascular event
  • Major liver, gastrointestinal, renal or endocrine disorder, diabetes mellitus with hypoglycemic drug(s)
  • Major sleep disorder, centrally acting medication
  • Lipid lowering drug, hypoglycemic drug, medication affecting the gut
  • Impaired glucose tolerance (pre-diabetes) or diabetes mellitus
  • Positive pregnancy test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Inselspital, Klinik für Allgemeine Innere Medizin

Bern, Canton of Bern, 3010, Switzerland

Location

University Hospital of Lausanne (CHUV)

Lausanne, 1011, Switzerland

Location

Related Publications (4)

  • Buso G, Favre L, Vionnet N, Gonzalez-Rodriguez E, Hans D, Puder JJ, Dubath C, Eap CB, Raffoul W, Collet TH, Mazzolai L. Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema. Obes Facts. 2022;15(6):762-773. doi: 10.1159/000527138. Epub 2022 Oct 28.

    PMID: 36310013BACKGROUND
  • Phillips NE, Mareschal J, Schwab N, Manoogian ENC, Borloz S, Ostinelli G, Gauthier-Jaques A, Umwali S, Gonzalez Rodriguez E, Aeberli D, Hans D, Panda S, Rodondi N, Naef F, Collet TH. The Effects of Time-Restricted Eating versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in Community-Based Adults. Nutrients. 2021 Mar 23;13(3):1042. doi: 10.3390/nu13031042.

    PMID: 33807102BACKGROUND
  • Borloz S, Bucher Della Torre S, Collet TH, Jotterand Chaparro C. Consumption of Ultraprocessed Foods in a Sample of Adolescents With Obesity and Its Association With the Food Educational Style of Their Parent: Observational Study. JMIR Pediatr Parent. 2021 Nov 15;4(4):e28608. doi: 10.2196/28608.

    PMID: 34779776BACKGROUND
  • Papageorgiou M, Biver E, Mareschal J, Phillips NE, Hemmer A, Biolley E, Schwab N, Manoogian ENC, Gonzalez Rodriguez E, Aeberli D, Hans D, Pot C, Panda S, Rodondi N, Ferrari SL, Collet TH. The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial. Obesity (Silver Spring). 2023 Feb;31 Suppl 1(Suppl 1):85-95. doi: 10.1002/oby.23577. Epub 2022 Oct 14.

    PMID: 36239695BACKGROUND

MeSH Terms

Conditions

Feeding BehaviorMetabolic SyndromeObesityDyslipidemiasGlucose IntoleranceFatty LiverIntermittent Fasting

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsLipid Metabolism DisordersHyperglycemiaLiver DiseasesDigestive System DiseasesFasting

Study Officials

  • Tinh-Hai Collet, MD

    University of Lausanne Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Study Part 1: Prospective longitudinal observational study. Study Part 2/3: Open-label randomized controlled trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 2, 2017

First Posted

August 7, 2017

Study Start

September 29, 2017

Primary Completion

March 31, 2021

Study Completion

March 31, 2022

Last Updated

December 6, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

Anonymized dataset of selected variables that underlie results in a publication. Some data may not be amenable to complete anonymization and will not be shared to ensure appropriate confidentiality of participant's data.

Shared Documents
STUDY PROTOCOL
Time Frame
Starting 6 months after publication
Access Criteria
Upon appropriate data request by other scientists

Locations